Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Afatinib With CT and RT for EGFR-Mutant NSCLC

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Massachusetts General Hospital
Information provided by (Responsible Party):
Lecia V. Sequist, Massachusetts General Hospital Identifier:
First received: March 5, 2012
Last updated: September 23, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)